Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma

Identification of Two Novel Immune Subtypes Characterized by Distinct Prognosis and Tumor Microenvironment in Osteosarcoma

Osteosarcoma is a kind of primary malignant tumor of bone. In recent years, its therapeutic effect and prognostic survival are dissatisfactory. The tumor immune microenvironment (TIME) reflects immune status of patients, but it is little known in osteosarcoma. Therefore, this study attempts to condu...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shunhan Yao, Meiling Deng, Xiaojing Du, Qingfeng Chen, Rongzhi Huang
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2022/2181525
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma
by: Yang Zhou, et al.
Published: (2022-01-01)

A telomere-related signature for predicting prognosis and assessing immune microenvironment in osteosarcoma
by: Shihao Li, et al.
Published: (2025-01-01)

Immunotherapy of osteosarcoma based on immune microenvironment modulation
by: Heping Lian, et al.
Published: (2025-01-01)

Identification of Hypoxia Signature to Assess the Tumor Immune Microenvironment and Predict Prognosis in Patients with Ovarian Cancer
by: Chunyan Wei, et al.
Published: (2021-01-01)

NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance
by: Shaoyan Shi, et al.
Published: (2025-01-01)

Immune infiltrate populations within distinct tumor immune microenvironments predictive of immune checkpoint treatment outcome
by: Brian Z Ring, et al.
Published: (2025-01-01)

Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma
by: Lin Zhang, et al.
Published: (2025-01-01)

Disulfidptosis-related immune patterns predict prognosis and characterize the tumor microenvironment in oral squamous cell carcinoma
by: Xuechen Wu, et al.
Published: (2025-02-01)

Viral Transcript and Tumor Immune Microenvironment-Based Transcriptomic Profiling of HPV-Associated Head and Neck Squamous Cell Carcinoma Identifies Subtypes Associated with Prognosis
by: Anastasiia Nikitina, et al.
Published: (2024-12-01)

Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer
by: Ke Zhu, et al.
Published: (2021-01-01)

Identification of PANoptosis associated lncRNAs associated with clinical prognosis and immune infiltration microenvironment in colon adenocarcinoma
by: Yangyang Wang, et al.
Published: (2025-01-01)

Application of Bionanomaterials in Tumor Immune Microenvironment Therapy
by: Jiawei Wang, et al.
Published: (2021-01-01)

Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma
by: Licheng Li, et al.
Published: (2022-01-01)

MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy
by: Gaofeng Ni, et al.
Published: (2025-02-01)

Identification of Ferroptosis-Associated Long Noncoding RNA Prognostic Model and Tumor Immune Microenvironment in Thyroid Cancer
by: Yongjian Lin, et al.
Published: (2022-01-01)

Classification of distinct tendinopathy subtypes for precision therapeutics
by: Chenqi Tang, et al.
Published: (2024-11-01)

Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical Cancer
by: Xiaolin Lang, et al.
Published: (2022-01-01)

Trogocytosis-mediated immune evasion in the tumor microenvironment
by: Jeonghyun Kim, et al.
Published: (2025-01-01)

Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion
by: Yang Xia, et al.
Published: (2025-01-01)

Assessment of MGMT and TERT Subtypes and Prognosis of Glioblastoma by Whole Tumor Apparent Diffusion Coefficient Histogram Analysis
by: Ling Chen, et al.
Published: (2025-01-01)

Deciphering the heterogeneity and plasticity of the tumor microenvironment in liver cancer provides insights for prognosis
by: Yihao Sun, et al.
Published: (2025-01-01)

Pan-Cancer Analysis of Disulfidptosis-Related Genes Affecting Prognosis and Tumor Microenvironment
by: Jingyang SUN, et al.
Published: (2025-01-01)

Identification and Functional Analysis of EPOR+ Tumor-Associated Macrophages in Human Osteosarcoma Lung Metastasis
by: Yanxing Li, et al.
Published: (2020-01-01)

Author Correction: Classification of distinct tendinopathy subtypes for precision therapeutics
by: Chenqi Tang, et al.
Published: (2025-01-01)

Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
by: Xiang Wang, et al.
Published: (2025-01-01)

Tumor-associated-fibrosis and active collagen-CD44 axis characterize a poor-prognosis subtype of gastric cancer and contribute to tumor immunosuppression
by: Yingqi Yang, et al.
Published: (2025-01-01)

Characterization of m6A Methylation Modification Patterns in Colorectal Cancer Determines Prognosis and Tumor Microenvironment Infiltration
by: Qingfang Yue, et al.
Published: (2022-01-01)

Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with Pancreatic Cancer
by: Tianle Zou, et al.
Published: (2023-01-01)

The Potential Impact of HNRNPA2B1 on Human Cancers Prognosis and Immune Microenvironment
by: Tao Huang, et al.
Published: (2024-01-01)

Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma
by: Xiangjun Qi, et al.
Published: (2022-01-01)

Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma
by: Ji Sun, et al.
Published: (2022-01-01)

Correction: Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
by: Shanqi Li, et al.
Published: (2024-12-01)

Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma
by: JinSong Li, et al.
Published: (2025-02-01)

Editorial: Tertiary lymphoid structures (TLS) in the tumor immune microenvironment
by: Xinbo Gao, et al.
Published: (2025-01-01)

Chiral polypeptide hydrogels regulating local immune microenvironment and anti-tumor immune response
by: Junfeng Ding, et al.
Published: (2025-01-01)

The Emerging Role of GC-MSCs in the Gastric Cancer Microenvironment: From Tumor to Tumor Immunity
by: Zhaoji Pan, et al.
Published: (2019-01-01)

Epigenetic Regulation of Stromal and Immune Cells and Therapeutic Targets in the Tumor Microenvironment
by: Kang Liu, et al.
Published: (2025-01-01)

HLA-DMB correlates with antitumor immunity and an improved prognosis in endometrial carcinoma tumors
by: Xiaoyu Xi, et al.
Published: (2025-01-01)

Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment
by: Qibo Huang, et al.
Published: (2025-01-01)

Do Not Miss the Tumor: A Novel Presentation of Osteosarcoma
by: Michael DePalma, et al.
Published: (2021-01-01)